MedPath

Mind Programme for Women With Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer Female
Interventions
Behavioral: Mind
Behavioral: Support Group
Registration Number
NCT05642897
Lead Sponsor
University of Coimbra
Brief Summary

The Mind programme for cancer patients was developed by this project PI through the integration of ACT, mindfulness and CFT components specifically adapted to the needs of a cancer population. This intervention aims at improving well-being, preventing subsequent distress, and promoting adaptation to the disease and posttreatment period. A recent pilot study presented preliminary findings on this intervention, suggesting high acceptability and efficacy in improving self-reported psychological health in breast cancer patients undergoing Radiotherapy treatment. Nevertheless, this study's small sample size, methodology (inactive control group), and exclusive reliance on self-reported data limit the interpretation and generalization of results, creating an avenue for the optimization and further testing of the programme through more robust and reliable methods. The aim of this project is therefore to optimize the Mind programme taking into consideration the results from its pilot study and to conduct a Randomized Controlled Trial on the efficacy of the intervention in improving not only mental health outcomes but also biological markers, as well as on its cost-effectiveness, in women with breast cancer. The superiority of the Mind programme will be compared to a support group intervention through the analysis of changes in cancer-specific quality of life, depressive symptoms and anxiety severity, psychological experiences, and immunological and epigenetics markers related to mental health and breast cancer prognosis. All participants will receive the intervention that shows better results.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
150
Inclusion Criteria
  1. age between 18-70;
  2. primary diagnosis of BC (stages between I and III);
  3. undergoing radiotherapy treatment at CHUC;
  4. able to understand and answer to self-report questionnaires in Portuguese.
Exclusion Criteria
  1. currently undergoing any form of psychological intervention;
  2. current diagnosis of severe psychiatric illness (psychotic disorder, bipolar disorder, substance abuse, and personality disorder) or suicidal ideation;
  3. diagnosis of neurological disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MindMindThe Mind programme is an ACT, mindfulness and compassion intervention for women with breast cancer. It will include 8 weekly group sessions, with the duration of 120 minutes each, and will be delivered at the Radiotherapy Service of the CHUC or through an online platform. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.
Support groupSupport GroupA support group intervention, with 8 weekly 90-120-minute sessions, will be delivered to the active control group at the Radiotherapy Service of the CHUC or through an online platform. All participants will continue on receiving the recommended medical treatment for their clinical diagnosis.
Primary Outcome Measures
NameTimeMethod
Cancer-specific quality of lifeBaseline, post-treatment (2 months after baseline), and 6-months follow-up

EORTC QLQ-C30 - Quality of Life, the higher the score, the higher the QoL level

Secondary Outcome Measures
NameTimeMethod
General quality of lifeBaseline, post-treatment (2 months after baseline), and 6-months follow-up

EQ-5D-5L, the higher the score, the higher the QoL level

Psychological flexibilityBaseline, post-treatment (2 months after baseline), and 6-months follow-up

Comprehensive Assessment of Acceptance and Commitment Therapy's Processes, the higher the score, the higher psychological flexibility level

Depressive symptoms and anxiety severityBaseline, post-treatment (2 months after baseline), and 6-months follow-up

HADS, the higher the score, the higher anxiety and depression level

Consumption of resources and costsBaseline, post-treatment (2 months after baseline), and 6-months follow-up

To collect data regarding resources used by participants outside the hospital setting, the research team developed a questionnaire adapted from the UK Cancer Costs Questionnaire (UKCC) Version 2.0 (http://blogs.ed.ac.uk/ukcc). Hospital costs will be taken from clinical registries.

Self-compassion and mindfulnessBaseline, post-treatment (2 months after baseline), and 6-months follow-up

Self-compassion Scale, the higher the score, the higher the self-compassion or mindfulness level

Immunological and epigenetic markersBaseline, post-treatment (2 months after baseline) and 6-months follow-up

Immunology indicators. Inflammatory biomarkers formerly associated with depression and anxiety (e.g., CRP, IL-6 and TNFalpha); biomarkers of the development of effective immune surveillance (e.g., IFNgamma, IL-12/18, GM-CSF); suppressive cytokines that may block the development of effective anti-tumour immune responses (e.g., IL-10, IL-4/13).

Epigenetics indicators. Expression of miRs associated with stress response, inflammation, or BC prognosis (miR-21, miR-146a, miR-155, and miR-Let7).

Major life events questionnaire - controlling variable6-months follow-up

Major Life Event Questionnaire, the higher the score, the higher the number of major life events in the previous year

ACT processes (Hexa(in)Flex Interview)Baseline

Hexa(in)Flex Interview is a semi-structured interview that aims to assess qualitatively the subjective experience of the 6 core processes of the Psychological (In)Flexibility Model underlying ACT in women with breast cancer. The interview has two parts: 1) an introduction to the aims of the interview, as well as introductory questions regarding diagnostic information (e.g., duration of diagnosis, treatment phase, support network) and general coping and adaptation to the cancer diagnosis; 2) Five sections of open questions aiming to assess: experiential avoidance versus acceptance, cognitive fusion versus defusion, conceptual versus contextual self, Past and future conceptualized (auto-pilot) versus contact with present moment, and lack of values clarity and action versus commitment to valued action. Each section has instructions on how the interviewer should conduct the questioning, as well as additional tips and caveats that should be considered.

Trial Locations

Locations (1)

Radiotherapy Service of the Coimbra University Hospital (CHUC)

🇵🇹

Coimbra, Portugal

© Copyright 2025. All Rights Reserved by MedPath